268 related articles for article (PubMed ID: 26432925)
21. Rapid determination of C4-acylcarnitine and C5-acylcarnitine isomers in plasma and dried blood spots by UPLC-MS/MS as a second tier test following flow-injection MS/MS acylcarnitine profile analysis.
Forni S; Fu X; Palmer SE; Sweetman L
Mol Genet Metab; 2010 Sep; 101(1):25-32. PubMed ID: 20591710
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
[TBL] [Abstract][Full Text] [Related]
23. Analysis of acylcarnitine profiles in umbilical cord blood and during the early neonatal period by electrospray ionization tandem mass spectrometry.
Vieira Neto E; Fonseca AA; Almeida RF; Figueiredo MP; Porto MA; Ribeiro MG
Braz J Med Biol Res; 2012 Jun; 45(6):546-56. PubMed ID: 22488223
[TBL] [Abstract][Full Text] [Related]
24. Liquid chromatography-tandem mass spectrometry method for estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
Natarajan A; Christopher R; Netravathi M; Bhat M; Chandra SR
Clin Chim Acta; 2018 Oct; 485():305-310. PubMed ID: 30018013
[TBL] [Abstract][Full Text] [Related]
25. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
[TBL] [Abstract][Full Text] [Related]
26. Newborn screening of inborn errors of metabolism by capillary electrophoresis-electrospray ionization-mass spectrometry: a second-tier method with improved specificity and sensitivity.
Chalcraft KR; Britz-McKibbin P
Anal Chem; 2009 Jan; 81(1):307-14. PubMed ID: 19117458
[TBL] [Abstract][Full Text] [Related]
27. Expanded newborn screening of inborn errors of metabolism by capillary electrophoresis-electrospray ionization-mass spectrometry (CE-ESI-MS).
Britz-McKibbin P
Methods Mol Biol; 2013; 919():43-56. PubMed ID: 22976089
[TBL] [Abstract][Full Text] [Related]
28. Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry.
De Jesús VR; Chace DH; Lim TH; Mei JV; Hannon WH
Clin Chim Acta; 2010 May; 411(9-10):684-9. PubMed ID: 20122909
[TBL] [Abstract][Full Text] [Related]
29. Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.
Hong X; Kumar AB; Ronald Scott C; Gelb MH
Mol Genet Metab; 2018 Jun; 124(2):101-108. PubMed ID: 29680633
[TBL] [Abstract][Full Text] [Related]
30. Improving Harmonization and Standardization of Expanded Newborn Screening Results by Optimization of the Legacy Flow Injection Analysis Tandem Mass Spectrometry Methods and Application of a Standardized Calibration Approach.
Carling RS; Whyte E; John C; Garstone R; Goddard P; Greenfield T; Hogg SL; Le Masurier C; Cowen S; Moat SJ; Hopley C
Clin Chem; 2022 Jul; 68(8):1075-1083. PubMed ID: 35699503
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China.
Tian GL; Xu F; Jiang K; Wang YM; Ji W; Zhuang YP
Clin Chim Acta; 2020 Apr; 503():157-162. PubMed ID: 31978407
[TBL] [Abstract][Full Text] [Related]
32. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
[TBL] [Abstract][Full Text] [Related]
33. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I.
Magera MJ; Gunawardena ND; Hahn SH; Tortorelli S; Mitchell GA; Goodman SI; Rinaldo P; Matern D
Mol Genet Metab; 2006 May; 88(1):16-21. PubMed ID: 16448836
[TBL] [Abstract][Full Text] [Related]
34. Quantification of Underivatized Amino Acids on Dry Blood Spot, Plasma, and Urine by HPLC-ESI-MS/MS.
Giordano G; Gucciardi A; Pirillo P; Naturale M
Methods Mol Biol; 2019; 2030():153-172. PubMed ID: 31347117
[TBL] [Abstract][Full Text] [Related]
35. Very long chain acylcarnitines and lysophosphatidylcholines in screening of peroxisomal disease in children by tandem mass spectrometry.
Wang Y; Tian G; Ji W; Wang S; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):481-486. PubMed ID: 34704420
[TBL] [Abstract][Full Text] [Related]
36. The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs.
la Marca G; Malvagia S; Pasquini E; Innocenti M; Fernandez MR; Donati MA; Zammarchi E
Rapid Commun Mass Spectrom; 2008; 22(6):812-8. PubMed ID: 18278819
[TBL] [Abstract][Full Text] [Related]
37. UPLC-MS/MS analysis of C5-acylcarnitines in dried blood spots.
Janzen N; Steuerwald U; Sander S; Terhardt M; Peter M; Sander J
Clin Chim Acta; 2013 Jun; 421():41-5. PubMed ID: 23499962
[TBL] [Abstract][Full Text] [Related]
38. Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots.
Allard P; Grenier A; Korson MS; Zytkovicz TH
Clin Biochem; 2004 Nov; 37(11):1010-5. PubMed ID: 15498530
[TBL] [Abstract][Full Text] [Related]
39. Identification of a neonate with hepatorenal tyrosinemia by combined routine newborn screening for succinylacetone, acylcarnitines and amino acids.
Al-Dirbashi OY; Fisher L; McRoberts C; Siriwardena K; Geraghty M; Chakraborty P
Clin Biochem; 2010 May; 43(7-8):691-3. PubMed ID: 19836366
[No Abstract] [Full Text] [Related]
40. Newborn screening for hepatorenal tyrosinemia-I by tandem mass spectrometry using pooled samples: a four-year summary by the New England newborn screening program.
Zytkovicz TH; Sahai I; Rush A; Odewale A; Johnson D; Fitzgerald E; Britton D; Eaton RB
Clin Biochem; 2013 May; 46(7-8):681-4. PubMed ID: 23462696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
